Zurex Pharma, a Middleton, WI-based startup developing antimicrobial products to prevent hospital-acquired infections, has raised $4.1 million from investors in a round that could top out at $5.1 million, according to a new SEC filing.
Zurex is working on three products: two that focus on catheter-related bloodstream infections and one that would avert infections in surgical wounds.
Read more at Xconomy.